BluPrint Oncology Concepts year founded2016 locationAtlanta, GA Public RelationsBluPrint is a medical strategy and communications company specializing in oncology and hematology. They bring science to life for some of the most well-known products in these areas. Learn More BlueCastle IT Solutions year...
Moonlight can detect cancer driver-gene events specific to the tumor and tissue of origin, including potential dual-role genes, as well as elucidate their downstream impact. To accomplish this, Moonlight integrates information from literature, pathways databases, and multiple -omics data into a comp...
Discover Oncology is an open access journal publishing content that interfaces at all levels of cancer research. Indexed in DOAJ, SCIE, PubMedCentral and SCOPUS with a CiteScore 2023 of 2.4. Covers basic and translational science, through to preclinical, clinical, and epidemiology. Formerly publishe...
According to the National Comprehensive Cancer Network (NCCN) practice guidelines [17] and the Chinese clinical guidelines from the Chinese Society of Clinical Oncology (CSCO) [18], S-1 alone or the XELOX (Xeloda and Oxaliplatin) regimen was first recommended for stage II GC as adjuvant ...
2023;73(1):17–48. Article PubMed Google Scholar Harbeck N, et al. Breast cancer. Nat Rev Dis Primers. 2019;5(1):66. Article PubMed Google Scholar Huang YY, et al. The top 100 most cited articles on triple-negative breast cancer: a bibliometric analysis. Clin Exp Med. 2023;23...
The impact of varying TLN1 expressions on overall survival in certain malignant tumor patients, based on GEPIA data from November 28, 2023. While not statistically significant, the trend indicated that higher TLN1 TPM correlates with better overall survival (OS) in CHOL (cholangio carcinoma), numbe...
A recent study conducted in the Netherlands, published in Journal of Clinical Oncology in July 2023, assessed cardiovascular disease (CVD) in TCS [58]. With a median follow up of 16 years, 5.73% patients had developed cardiovascular complications. TCS who received cisplatin had a higher risk of...
PeerJ. 2023;11:e16447. Article PubMed PubMed Central Google Scholar Wei Y, Zhai Y, Liu X, Jin S, Zhang L, Wang C, et al. Long non-coding RNA MIR31HG as a prognostic predictor for malignant cancers: a meta- and bioinformatics analysis. J Clin Lab Anal. 2022;36(1):e24082. ...
Oncol Rep. 2023;50:192. Article CAS PubMed PubMed Central Google Scholar Chen X, Kang R, Kroemer G, Tang D. Targeting ferroptosis in pancreatic cancer: a double-edged sword. Trends Cancer. 2021. https://doi.org/10.1016/j.trecan.2021.04.005. Article PubMed PubMed Central Google Scholar...
It is well known that both immunology and genetics perform important roles in the field of oncology, and that they are interrelated and work together to influence tumour development and treatment. The present study demonstrates the correlation between immune infiltration and SNV, CNV, methylation, cor...